BLUEJET Blue Jet Healthcare Q1 FY27 results (Apr–Jun 2026) and concall
Blue Jet Healthcare Limited reported a strong Q1 FY27, with revenue from operations reaching INR293 crores and operating EBITDA margin improving to 33.5%. The PI segment drove growth, while strategic projects like Vizag and Hyderabad R&D are progressing well. However, gross margins faced pressure from rising raw material costs and product mix, and contrast media revenue saw a sequential decline due to transit delays, with INR30 crores deferred to the next quarter.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue down 17.5%, net profit down 14.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 208 | 318 | 340 | 355 | 165 −21% | 192 −40% | 235 −31% | 293 −17% |
| EBITDA | 69 | 124 | 140 | 121 | 55 −20% | 47 −62% | 71 −49% | 98 −19% |
| Net profit | 58 | 99 | 110 | 91 | 52 −10% | 40 −60% | 64 −42% | 78 −14% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





